Compound details
Lycoposerramine O
| Compound ID | CDAMM01240 |
|---|---|
| Common name | Lycoposerramine O | IUPAC name | 5-[2-(4,8-dimethylnona-3,7-dienyl)-3,5-dihydroxy-2-methyl-7-oxo-4,9-dihydro-3H-pyrano[2,3-e]isoindol-8-yl]pentanoic acid |
| Molecular formula | C28H39NO6 |
| Retention time | 11.83 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 508.274 | Theoretical mz | 508.267 |
| Error | 13.74 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.7251 |
| Inchi key | RRMQRYDHWSWYHI-LHGPBLCONA-N |
|---|---|
| Smiles | O=C(O)CCCCN1C(=O)C2=CC(O)=C3C(OC(C)(CCC=C(C)CCC=C(C)C)C(O)C3)=C2C1 |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SwissTargetPrediction |
| P04818 | TYMS | Thymidylate synthase (by homology) | T98397 | SwissTargetPrediction |
| P12821 | ACE | Angiotensin-converting enzyme | T98311 | SwissTargetPrediction |
| P09960 | LTA4H | Leukotriene A4 hydrolase | T03691 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | T37848 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SwissTargetPrediction |
| P00747 | PLG | Plasminogen | T89034 | SwissTargetPrediction |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| Q96IY4 | CPB2 | Carboxypeptidase B2 isoform A | T98022 | SwissTargetPrediction |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SwissTargetPrediction |
| P06401 | PGR | Progesterone receptor | T22939 | SwissTargetPrediction |
| O14684 | PTGES | Prostaglandin E synthase | T02562 | SwissTargetPrediction |
| O14842 | FFAR1 | Free fatty acid receptor 1 | T25608 | SwissTargetPrediction |
| P11473 | VDR | Vitamin D receptor | T34234 | SwissTargetPrediction |
| Q8TDU6 | GPBAR1 | G-protein coupled bile acid receptor 1 | T86273 | SwissTargetPrediction |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SwissTargetPrediction |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SwissTargetPrediction |
| Q13133 | NR1H3 | LXR-alpha | T52297 | SwissTargetPrediction |
| P05121 | SERPINE1 | Plasminogen activator inhibitor-1 | T15556 | SwissTargetPrediction |
| P21731 | TBXA2R | Thromboxane A2 receptor | T76198 | SwissTargetPrediction |
| P62993 | GRB2 | Growth factor receptor-bound protein 2 | T30926 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P06213 | INSR | Insulin receptor | T85435 | SwissTargetPrediction |
| P55072 | VCP | Transitional endoplasmic reticulum ATPase | T12646 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P78536 | ADAM17 | ADAM17 | T82393 | SwissTargetPrediction |
| P09237 | MMP7 | Matrix metalloproteinase 7 | T73475 | SwissTargetPrediction |
| P42575 | CASP2 | Caspase-2 | T09128 | SwissTargetPrediction |
| P08172 | CHRM2 | Muscarinic acetylcholine receptor M2 | T46185 | SwissTargetPrediction |
| P23946 | CMA1 | Chymase | T05114 | SwissTargetPrediction |
| P00750 | PLAT | Tissue-type plasminogen activator | T45299 | SwissTargetPrediction |
| Q9HAN5 | TRP1 | Cationic trypsinogen | T27602 | SwissTargetPrediction |
| O43193 | MLNR | Motilin receptor | T62306 | SwissTargetPrediction |
| Q9Y5Y4 | PTGDR2 | G protein-coupled receptor 44 | T61722 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P04035 | HMGCR | HMG-CoA reductase | T53585 | SwissTargetPrediction |
| P11137 | MAP2 | Microtubule-associated protein 2 | T23276 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P01375 | TNF | TNF-alpha | T20178 | SwissTargetPrediction |
| P30556 | AGTR1 | Type-1 angiotensin II receptor | T74456 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P29466 | CASP1 | Caspase-1 | T98269 | SwissTargetPrediction |
| P40763 | STAT3 | Signal transducer and activator of transcription 3 | T29130 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| P20142 | PGC | Pepsinogen C (by homology) | T45601 | SwissTargetPrediction |
| P43115 | PTGER3 | Prostanoid EP3 receptor | T85467 | SwissTargetPrediction |
| P06756 | ITGAV | Vitronectin receptor alpha | T67103 | SwissTargetPrediction |
| P05556 | ITGB1 | Integrin alpha2/beta1 | T01851 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SwissTargetPrediction |
| P04629 | NTRK1 | Nerve growth factor receptor Trk-A | T07173 | SwissTargetPrediction |
| Q00535 | CDK5 | Cyclin-dependent kinase 5/CDK5 activator 1 | T20973 | SwissTargetPrediction |
| Q16620 | NTRK2 | Neurotrophic tyrosine kinase receptor type 2 | T84703 | SwissTargetPrediction |
| P42574 | CASP3 | Caspase-3 | T57943 | SwissTargetPrediction |
| P67775 | PPP2CA | Serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform | T40491 | SwissTargetPrediction |
| Q12908 | SLC10A2 | Ileal bile acid transporter | T24982 | SwissTargetPrediction |
| P24557 | TBXAS1 | Thromboxane-A synthase | T78356 | SwissTargetPrediction |
| P10619 | CTSA | Lysosomal protective protein | T37154 | SwissTargetPrediction |
| P32239 | CCKBR | Cholecystokinin B receptor (by homology) | T05849 | SwissTargetPrediction |
| P43088 | PTGFR | Prostanoid FP receptor | T75797 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| Q9H244 | P2RY12 | Purinergic receptor P2Y12 (by homology) | T46937 | SwissTargetPrediction |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | T99089 | SwissTargetPrediction |
| P24530 | EDNRB | Endothelin receptor ET-B | T92828 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| P10415 | BCL2 | Apoptosis regulator Bcl-2 | T31309 | SwissTargetPrediction |
| P03951 | F11 | Coagulation factor XI | T46040 | SwissTargetPrediction |
| O75173 | ADAMTS4 | ADAMTS4 | T79570 | SwissTargetPrediction |
| Q96DB2 | HDAC11 | Histone deacetylase 11 | T97903 | SwissTargetPrediction |
| P55055 | NR1H2 | LXR-beta | T13714 | SwissTargetPrediction |
| Q13332 | PTPRS | Receptor-type tyrosine-protein phosphatase S | T10147 | SwissTargetPrediction |
| Q969S8 | HDAC10 | Histone deacetylase 10 | T94324 | SwissTargetPrediction |
| O95136 | S1PR2 | Sphingosine 1-phosphate receptor Edg-5 | T47888 | SwissTargetPrediction |
| Q9Y271 | CYSLTR1 | Cysteinyl leukotriene receptor 1 | T71192 | SwissTargetPrediction |
| Q02790 | FKBP4 | FK506 binding protein 4 | T87020 | SwissTargetPrediction |
| P42229 | STAT5A | Signal transducer and activator of transcription 5A | T20027 | SwissTargetPrediction |
| Q9H4B7 | TUBB1 | Tubulin beta-1 chain | T84397 | SwissTargetPrediction |
| O43826 | SLC37A4 | Glucose-6-phosphate translocase | T47306 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T98397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04818 | TYMS |
| T98397 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P04818 | TYMS |
| T98311 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P12821 | ACE |
| T98311 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P12821 | ACE |
| T03691 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P09960 | LTA4H |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T37848 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P08684 | CYP3A4 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T89034 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00747 | PLG |
| T89034 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00747 | PLG |
| T89034 | DI0254 | Menopausal disorder | [ICD-11: GA30] | P00747 | PLG |
| T89034 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00747 | PLG |
| T89034 | DI0345 | Procedure injury | [ICD-11: NE81] | P00747 | PLG |
| T89034 | DI0357 | Pulmonary thromboembolism | [ICD-11: BB00] | P00747 | PLG |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T98022 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | Q96IY4 | CPB2 |
| T98022 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | Q96IY4 | CPB2 |
| T98022 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | Q96IY4 | CPB2 |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T22939 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06401 | PGR |
| T22939 | DI0100 | Contraceptive management | [ICD-11: QA21] | P06401 | PGR |
| T22939 | DI0255 | Menstrual cycle bleeding disorder | [ICD-11: GA20] | P06401 | PGR |
| T22939 | DI0344 | Preterm labour/delivery | [ICD-11: JB00] | P06401 | PGR |
| T22939 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06401 | PGR |
| T02562 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O14684 | PTGES |
| T25608 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O14842 | FFAR1 |
| T34234 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P11473 | VDR |
| T34234 | DI0171 | Hair/hair growth developmental defect | [ICD-11: LC30] | P11473 | VDR |
| T34234 | DI0189 | Hyper-parathyroidism | [ICD-11: 5A51] | P11473 | VDR |
| T34234 | DI0195 | Hypo-parathyroidism | [ICD-11: 5A50] | P11473 | VDR |
| T34234 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P11473 | VDR |
| T34234 | DI0351 | Psoriasis | [ICD-11: EA90] | P11473 | VDR |
| T34234 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | P11473 | VDR |
| T86273 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q8TDU6 | GPBAR1 |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T52297 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q13133 | NR1H3 |
| T15556 | DI0037 | Asthma | [ICD-11: CA23] | P05121 | SERPINE1 |
| T15556 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P05121 | SERPINE1 |
| T76198 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P21731 | TBXA2R |
| T76198 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P21731 | TBXA2R |
| T76198 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P21731 | TBXA2R |
| T76198 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P21731 | TBXA2R |
| T30926 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P62993 | GRB2 |
| T30926 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P62993 | GRB2 |
| T30926 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P62993 | GRB2 |
| T30926 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P62993 | GRB2 |
| T30926 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P62993 | GRB2 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T85435 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P06213 | INSR |
| T85435 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P06213 | INSR |
| T12646 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P55072 | VCP |
| T12646 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P55072 | VCP |
| T12646 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P55072 | VCP |
| T12646 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P55072 | VCP |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T82393 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P78536 | ADAM17 |
| T82393 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P78536 | ADAM17 |
| T73475 | DI0238 | Lung cancer | [ICD-11: 2C25] | P09237 | MMP7 |
| T46185 | DI0037 | Asthma | [ICD-11: CA23] | P08172 | CHRM2 |
| T46185 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08172 | CHRM2 |
| T46185 | DI0278 | Muscle disorder | [ICD-11: FB32-FB3Z] | P08172 | CHRM2 |
| T46185 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08172 | CHRM2 |
| T46185 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08172 | CHRM2 |
| T46185 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P08172 | CHRM2 |
| T05114 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23946 | CMA1 |
| T05114 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P23946 | CMA1 |
| T05114 | DI0169 | Gram-positive bacterial infection | [ICD-11: 1B74-1F40] | P23946 | CMA1 |
| T05114 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P23946 | CMA1 |
| T05114 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P23946 | CMA1 |
| T05114 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P23946 | CMA1 |
| T45299 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00750 | PLAT |
| T45299 | DI0345 | Procedure injury | [ICD-11: NE81] | P00750 | PLAT |
| T27602 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q9HAN5 | TRP1 |
| T27602 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9HAN5 | TRP1 |
| T62306 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | O43193 | MLNR |
| T62306 | DI0159 | Gastroduodenal motor/secretory disorder | [ICD-11: DA41] | O43193 | MLNR |
| T62306 | DI0161 | Gastro-oesophageal reflux disease | [ICD-11: DA22] | O43193 | MLNR |
| T62306 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O43193 | MLNR |
| T62306 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | O43193 | MLNR |
| T61722 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q9Y5Y4 | PTGDR2 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T53585 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P04035 | HMGCR |
| T53585 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P04035 | HMGCR |
| T53585 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P04035 | HMGCR |
| T53585 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P04035 | HMGCR |
| T53585 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04035 | HMGCR |
| T53585 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P04035 | HMGCR |
| T53585 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P04035 | HMGCR |
| T23276 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P11137 | MAP2 |
| T23276 | DI0252 | Melanoma | [ICD-11: 2C30] | P11137 | MAP2 |
| T23276 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P11137 | MAP2 |
| T23276 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11137 | MAP2 |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T20178 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P01375 | TNF |
| T20178 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P01375 | TNF |
| T20178 | DI0351 | Psoriasis | [ICD-11: EA90] | P01375 | TNF |
| T20178 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P01375 | TNF |
| T74456 | DI0137 | Essential hypertension | [ICD-11: BA00] | P30556 | AGTR1 |
| T74456 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P30556 | AGTR1 |
| T74456 | DI0373 | Secondary hypertension | [ICD-11: BA04] | P30556 | AGTR1 |
| T74456 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P30556 | AGTR1 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T98269 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P29466 | CASP1 |
| T98269 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P29466 | CASP1 |
| T98269 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P29466 | CASP1 |
| T98269 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P29466 | CASP1 |
| T29130 | DI0351 | Psoriasis | [ICD-11: EA90] | P40763 | STAT3 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T85467 | DI0166 | Glaucoma | [ICD-11: 9C61] | P43115 | PTGER3 |
| T85467 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P43115 | PTGER3 |
| T85467 | DI0414 | Transplanted organ/tissue | [ICD-11: QB63] | P43115 | PTGER3 |
| T67103 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P06756 | ITGAV |
| T67103 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06756 | ITGAV |
| T01851 | DI0060 | Brain cancer | [ICD-11: 2A00] | P05556 | ITGB1 |
| T01851 | DI0238 | Lung cancer | [ICD-11: 2C25] | P05556 | ITGB1 |
| T01851 | DI0365 | Retinopathy | [ICD-11: 9B71] | P05556 | ITGB1 |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T07173 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04629 | NTRK1 |
| T07173 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04629 | NTRK1 |
| T20973 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q00535 | CDK5 |
| T84703 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | Q16620 | NTRK2 |
| T84703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16620 | NTRK2 |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T40491 | DI0268 | Molluscum contagiosum | [ICD-11: 1E76] | P67775 | PPP2CA |
| T24982 | DI0349 | Pruritus | [ICD-11: EC90] | Q12908 | SLC10A2 |
| T78356 | DI0030 | Angina pectoris | [ICD-11: BA40] | P24557 | TBXAS1 |
| T37154 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P10619 | CTSA |
| T05849 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P32239 | CCKBR |
| T05849 | DI0327 | Pancreatic internal secretion disorder | [ICD-11: 5A4Y] | P32239 | CCKBR |
| T75797 | DI0003 | Abortion | [ICD-11: JA00] | P43088 | PTGFR |
| T75797 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P43088 | PTGFR |
| T75797 | DI0166 | Glaucoma | [ICD-11: 9C61] | P43088 | PTGFR |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T46937 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q9H244 | P2RY12 |
| T46937 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | Q9H244 | P2RY12 |
| T99089 | DI0252 | Melanoma | [ICD-11: 2C30] | P15056 | BRAF |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T31309 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10415 | BCL2 |
| T31309 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P10415 | BCL2 |
| T31309 | DI0273 | Motor neuron disease | [ICD-11: 8B60] | P10415 | BCL2 |
| T31309 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P10415 | BCL2 |
| T46040 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P03951 | F11 |
| T46040 | DI0089 | Clotting disorder | [ICD-11: 3B4Z] | P03951 | F11 |
| T13714 | DI0039 | Atopic eczema | [ICD-11: EA80] | P55055 | NR1H2 |
| T10147 | DI0057 | Bone paget disease | [ICD-11: FB85] | Q13332 | PTPRS |
| T94324 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q969S8 | HDAC10 |
| T47888 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | O95136 | S1PR2 |
| T71192 | DI0037 | Asthma | [ICD-11: CA23] | Q9Y271 | CYSLTR1 |
| T84397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H4B7 | TUBB1 |